Latest news
Latham & Watkins Advises on Latigo Biotherapeutics’ Upsized US$345.6 Million Initial Public Offering - Latham & Watkins LLPLatham & Watkins LLP · Fri, 07 Aug 2026 20:34:02 GMTBraveheart Bio Shares Begin Nasdaq Trading After $439.9M IPO - Stock TitanStock Titan · Fri, 07 Aug 2026 20:05:00 GMTPress Release: Braveheart Bio Announces Closing of Upsized Initial Public Offering Including Full Exercise of Underwriters' Option to Purchase Additional Shares - MoomooMoomoo · Fri, 07 Aug 2026 20:05:00 GMTBlossomHill Therapeutics Announces Pricing of Upsized $150 Million Initial Public Offering - Yahoo Finance SingaporeYahoo Finance Singapore · Fri, 07 Aug 2026 00:07:00 GMTLatigo Biotherapeutics Announces Pricing of Upsized $345.6 Million Initial Public Offering - GlobeNewswireGlobeNewswire · Fri, 07 Aug 2026 00:03:00 GMTAttovia Therapeutics Announces Closing of Upsized Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares - Yahoo Finance SingaporeYahoo Finance Singapore · Thu, 06 Aug 2026 20:05:00 GMTBraveheart Bio Expects Nasdaq Debut Aug. 6 After $18 IPO - Stock TitanStock Titan · Thu, 06 Aug 2026 02:36:06 GMTCadillac Mines Corporation Announces Closing of Upsized Initial Public Offering and Exercise of Over-Allotment Option in Full - Yahoo FinanceYahoo Finance · Wed, 05 Aug 2026 13:10:00 GMT